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Abstract
Background: Although advanced age is considered a risk factor for several diseases, the impact of gender on age-
associated cardiovascular diseases, such as atherosclerotic processes and valvular diseases, remains not completely
clarified. The present study was designed to assess aortic valve morphology and function and vascular damage in
elderly using the apolipoprotein E knockout (ApoE KO) mouse. Our hypothesis was that advanced age-related
cardiovascular changes are aggravated in atherosclerotic male mice.
Methods: The grade (0 to 4) of aortic regurgitation was evaluated through angiography. In addition, vascular lipid
deposition and senescence were evaluated through histochemical analyses in aged male and female ApoE KO
mice, and the results were compared to wild-type C57BL/6J (C57) mice.
Results: Aortic regurgitation was observed in 92% of the male ApoE KO mice and 100% of the male C57 mice.
Comparatively, in age-matched female ApoE KO and C57 mice, aortic regurgitation was observed in a proportion
of 58% and 53%, respectively. Histological analysis of the aorta showed an outward (positive) remodeling in ApoE
KO mice (female: 1.86 ± 0.15; male: 1.89 ± 0.68) using C57 groups as reference values. Histochemical evaluation of
the aorta showed lipid deposition and vascular senescence only in the ApoE KO group, which were more
pronounced in male mice.
Conclusion: The data show that male gender contributes to the progression of aortic regurgitation and that
hypercholesterolemia and male gender additively contribute to the occurrence of lipid deposition and vascular
senescence in elderly mice.
Background
Although several studies have characterized advanced
age as a risk factor for cardiovascular diseases [1,2], the
impact of gender on age-associated cardiovascular per-
formance remains to be completely delineated [3,4].
This question is important because gender-related dif-
ferences in cardiovascular aging, such as atherosclerotic
processes and valvular diseases, may help to explain, in
part, the greater longevity of females [5,6].
Over the past few decades, the availability of new
investigative tools, including the homozygous apolipo-
protein E knockout (ApoE KO) mouse, has contributed
to understanding the atherosclerotic process and
cardiovascular diseases [7,8]. ApoE is a constituent of
VLDL synthesized by the liver, mediates high-affinity
binding of ApoE containing lipoprotein particles to LDL
receptors, and is responsible for the cellular uptake of
these particles [9]. Therefore, the ApoE KO mouse
develops marked hypercholesterolemia and spontaneous
atherosclerosis [9-11]. In this experimental model, the
influence of gender has been reported only with Wes-
tern-type cholesterol-rich diets in young adult mice
[12,13], but the impact of both elderly and gender on
cardiovascular function has not been elucidated.
In the present study, our hypothesis was that
advanced age affects the cardiovascular structure of
atherosclerotic mice, which could be aggravated in
males. On a normal chow diet, ApoE KO mice were
subjected to in vivo angiography and to in vitro histo-
chemical analysis to characterize valve and aortic
morphology.
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Animals
Aged male and female mice (18 months old) were ran-
domly divided into four groups: C57 (females: n = 26;
males: n = 22) and ApoE KO (females: n = 28; males:
n = 23). Animals were obtained from the animal facil-
ities of the Laboratory of Transgenes and Cardiovascular
Control at the Federal University of Espirito Santo. Mice
were fed a normal chow diet and water ad libitum and
were housed separately in temperature-controlled rooms
(22°C) under a 12 h light/dark cycle. All procedures
were conducted in accordance with the institutional
guidelines for animal research and the protocols were
previously approved by the Institutional Ethics Commit-
tee for Use of Animals (CEUA 001/2009).
Angiographic Analysis
Mice were anesthetized with ketamine/xylazine (91.0/9.1
mg/kg, IP) and polyethylene catheters (PE10 - PE50)
filled with heparinized (10 UI/mL) saline were inserted
into the right carotid artery for the contrast agent infu-
sion. Each mouse was placed in a supine position to
obtain images at 0° and 45° with an angiographic X-ray
System (Shimadzu Corporation, Japan) at a speed of 5
frames/s. The X-ray angiography was performed with a
manual injector that was controlled to reproducibly deli-
ver 0.15 mL/s of non-ionic contrast media containing
35% iodine (Telebrix; Guerbet, France) for 3 s. Serial
images of each mouse were then recorded and the aorta
internal diameter analyzed by quantitative coronary ana-
lysis software (QCA, Shimadzu Corporation, Japan).
Detection of aortic regurgitation (AR) was evaluated by
intensity, extension and persistence of contrast after
successive systoles and classified by grades of severity
(0 to 4) based on the study of Pujadas [14].
Cardiopulmonary parameters
The wet weight of the lung was measured and the tissue
was then placed in an oven at 60°C for 24 h. The lungs
water content (%H2O) was determined as follows [15]:
%H2O = (wet weight - dry weight)/wet weight × 100.
Cardiac wet weight was used to determine the cardiac
weight/body weight ratio.
Histological Valve and Vessel Processing
A tt h ee n do ft h ee x p e r i m e n t s ,m i c ew e r ee u t h a n i z e d
with sodium thiopental overdose (100 mg/kg, IP) and
perfused via the left ventricle with phosphate-buffered
saline (PBS, pH 7.4; 0.1 M) followed by a fixative solu-
tion of formaldehyde (4%) at a pressure of 100 mmHg.
After remaining overnight in the fixative solution, the
p e r i v a s c u l a ra d i p o s et i s s u eo ft h ea o r t aw a sr e m o v e d .
The aortic valve and the portion of the ascendant aorta
were embedded in a 24% gelatin solution and then
cross-sectioned at a 10-μm thickness using a cryostat
(Jung CM1800; Leica, Wetzlar, Germany). For each
animal, aorta cross-sections were mounted on gelatin-
coated slides and stained with Oil-Red-O (Sigma-
Aldrich, St. Louis, MO, USA) for neutral lipids detection
and stained with hematoxylin (Sigma-Aldrich) for valve
morphological analysis which was done by an indepen-
dent investigator. Extreme care was taken in sectioning
the heart so that the valves were cut transversely. For
longitudinal analysis, the hearts were embedded in par-
affin and cut on a longitudinal plane with sections of 8-
12 μm thickness. The slides were stained with hematox-
ylin-eosin for detection of cellularity and thickness. The
slides were also stained with Masson’st r i c h r o m ef o r
detection of the presence of fibrosis and with von Kossa
for calcification analysis. The remnant whole aorta was
opened lengthwise and stained en face for lipid deposi-
tion and vascular senescence activity.
Senescence Activity b-Gal Staining
Staining for senescence by b-gal activity was performed
as described by Minamino et al. [16]. Briefly, en face
aortic samples were incubated for 24 h at 37°C in
freshly prepared b-gal staining solutions (pH 6.0) con-
taining 2.4 mM 5-bromo-4-chrolo-3-indlyl-D-galacto-
pyranoside (X-gal, Sigma Aldrich), 4.7 mmol/L
potassium ferrocyanide, 4.9 mmol/L potassium ferricya-
nide, 150 mmol/L NaCl, 1 mmol/L MgCl2 and 40
mmol/L citric acid. The senescence analysis was per-
formed by detection of blue color produced by the enzy-
matic reaction and the images were captured with a
photographic camera (Canon, USA). The quantification
of senescence was performed using an National Insti-
tutes of Health (NIH) Image program (Image-J 1.35 d,
NIH, Bethesda, USA) and the examiner was blinded to
the experimental groups.
Morphometry
Images of the aorta and the valve were captured with a
color video camera (VKC150,H i t a c h i ,T o k y o ,J a p a n )
connected to a microscope (Olympus AX70, Olympus,
Center Valley, PA, USA). Analysis was conducted with a
Leica image program (2100 Leica EWS; Leica, Wetzlar,
Germany) and an NIH Image program by an examiner
blinded to the experimental groups. The program was
calibrated with a graduated slide. By using a 4× objec-
tive, the vessel cross-sectional area (VCSA)a n dt h e
lumen cross-sectional area were calculated. The vascular
remodeling ratio was obtained by dividing each animal’s
VCSA by the average VCSA of the C57 group and each
sample was classified as absence (0.95-1.05), inward
(<0.95), or outward (>1.05) remodeling. In the left
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width of at least 10 cardiomyocytes were measured for
seven mice from each group.
Measurement of Plasma Cholesterol Levels
A blood sample (200 μL) was taken from the carotid
artery of each animal and the plasma total cholesterol
was measured using a commercial colorimetric kit (Bio-
clin, Belo Horizonte, Brazil).
Statistical Analysis
Continuous variables are presented as mean ± SEM. Sta-
tistical analysis was performed with a one-way analysis
of variance (ANOVA), followed by the Tukey post hoc
test for multiple comparisons of continuous variables
between groups. Student’s t-test for independent sam-
ples was used when appropriate. Categorical variables
are presented as frequencies and were compared using
the Fisher’s exact test. The significance level was set at
p < 0.05.
Results
Table 1 summarizes the average values of body and car-
diac weight, cardiac myocyte size, pulmonary water con-
tent and plasma cholesterol levels. At the time of the
experiments, body weight did not differ between C57 and
ApoE KO groups. As expected, total plasma cholesterol
levels were significantly higher in ApoE KO females (4.1-
fold, p < 0.001) and males (6.7-fold, p < 0.001) than in
females and males of the C57 group. Plasma cholesterol
levels were significantly augmented (93%; p < 0.001) in
aged male compared with aged female ApoE KO mice.
Based on cardiac weight/body weight ratio and myocyte
size, cardiac hypertrophy was not observed in male as
compared to female animals in either C57 or ApoE KO
groups. Also, an increase in pulmonary water content
was not observed between groups.
Using angiography with injection of iodized contrast,
we found a remarkable aortic regurgitation in aged
ApoE KO and C57 males compared with aged females
(Figure 1, bottom panel). The proportion of male mice
(96%) with aortic regurgitation (grades 1-4) was signifi-
cantly higher than of female mice (51%) when grouping
ApoE KO and C57 animals (p = 0.0008). When the
Table 1 Body and cardiac weight, cardiomyocyte size, pulmonary water content and plasma cholesterol levels of C57
and ApoE KO
Groups
Parameters C57 ApoE KO
Female Male Female Male
Body weight (g) 31 ± 0.9 33 ± 0.7 30 ± 0.5 32 ± 0.7
Cardiac weight/body weight ratio (mg/g) 5.9 ± 0.4 5.7 ± 0.4 6.0 ± 0.4 5.9 ± 0.3
Cardiomyocytes width (μm) 15 ± 0.1 15 ± 0.2 15 ± 0.1 15 ± 0.1
Pulmonary water content (%) 76 ± 0.6 76 ± 1.2 75 ± 0.5 76 ± 0.9
Plasma cholesterol (mg/dL) 81 ± 4 96 ± 7 336 ± 32* 650 ± 92
# *
Values are means ± SEM. 7 to 11 animals per group.
*p < 0.001 vs C57 group and
#p < 0.001 vs female (ANOVA)
Figure 1 Influence of gender on aortic regurgitation in aged
normocholesterolemic and hypercholesterolemic mice. Top
panel: typical angiographies showing aortic regurgitation in the
male (right image) but not in the female (left image). Bottom panel:
scatter plot showing the severity of aortic regurgitation (grades: 0 =
none, 1 = light, 2 = mild, 3 = moderate, 4 = severe) in males
compared with females in both C57 and ApoE KO groups.
Horizontal bars represent the median for each group. p values were
calculated using the Fisher’s exact test and indicate statistical
significance between proportions. The number of animals per group
is shown in parentheses.
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group the proportion of animals with aortic regurgita-
tion was significantly higher in males than in females
(100% vs 53%; p = 0.006). Similar results were observed
in the hypercholesterolemic ApoE KO group (92% vs
58%; p = 0.02). A typical angiography of an aged female
without aortic regurgitation (left image) and a typical
angiography of an aged male with (right image) aortic
regurgitation are shown in the top panel of Figure 1.
Figure 2 illustrates the results of histological examina-
tions of the heart showing the thickening of aortic
valves in aged males compared with females of the C57
g r o u p( 1 0 6±4v s3 2±5μm, respectively; p < 0.001)
and, more significantly, in aged males compared with
f e m a l e so ft h eA p o EK Og r o u p( 1 8 6±3v s6 9±6μm,
respectively; p < 0.001). The analysis of longitudinal
valvular sections of aged males (Figure 3) showed acellu-
larity, glycosaminogycan transformation and fibrosis of
the sponge layer of the leaflet mainly in ApoE KO mice.
Valvular calcifications were not observed in C57 or
ApoE KO animals.
The angiographic analysis in the four segments of the
aorta did not show significant differences in the internal
diameter between groups as illustrated in Figure 4.
Figure 5 (bottom panel) summarizes the data of the
cross section area of the ascending aorta, showing a simi-
lar lumen area in all groups. However, the vessel area
was significantly increased in female (2364 ± 192 μm
2)
and male (2869 ± 102 μm
2) ApoE KO mice, compared
with C57 mice (1274 ± 175 and 1517 ± 283 μm
2,r e s p e c -
tively; p < 0.05). Consequently, a positive (>1.05) vascular
remodeling was observed in both female (1.86 ± 0.15)
and male (1.89 ± 0.68) ApoE KO mice, using the C57
animals as reference values. The top panel of Figure 5
shows typical photomicrographs of ascending aorta cross
sections, indicating an outward vascular remodeling in an
ApoE KO compared with a C57 mouse.
In the histochemical evaluation of the aorta (Figure 6),
calcium deposition was observed only in the ApoE KO
group and mainly in male animals (panel A). En face
whole aorta analysis (panel B) showed greater lipid
deposition in female and male ApoE KO mice (0.21 ±
0.04 and 0.35 ± 0.05 cm
2)w h e nc o m p a r e dw i t hC 5 7
mice (0.11 ± 0.01 and 0.12 ± 0.01 cm
2, respectively) (p
< 0.05). Panel C shows representative en face analysis of
vascular senescence (b-gal positive cells). An increase in
stained area was observed in the aorta of female and
male ApoE KO mice (0.025 ± 0.02 and 0.19 ± 0.08 cm
2,
respectively) as compared with C57 mice (0.010 ± 0.008
and 0.016 ± 0.009 cm
2, respectively) (p < 0.05).
Discussion
This study describes the functional and structural valvu-
lar and vascular changes by gender in normal and
Figure 2 Typical photomicrographs of the aortic valves of male and female mice from the normocholesterolemic C57 and
hypercholesterolemic ApoE KO groups. Squares indicate the maximum thickness of each valve. Arrows indicate valvar lesions in males of
both C57 and ApoE KO groups as indicated by hemosiderin deposition. The sections were stained with both Oil-Red-O and hematoxylin.
Magnification: 400×.
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gender is an important factor for the progression of aor-
tic regurgitation in both normocholesterolemic (C57)
and hypercholesterolemic (ApoE KO) mice. In addition
to male gender, hypercholesterolemia also contributes to
the occurrence of vascular senescence in elderly mice.
In contrast, the outward (positive) remodeling observed
in aortas of ApoE KO mice was not influenced by
gender.
Diagnostic imaging methods used for investigating
human cardiovascular diseases have also been used in
rats [17] and with limitations in mice [8,18]. While mea-
suring the internal diameter of the aorta through angio-
graphy, we incidentally observed aortic regurgitation in
elderly male mice. Age-related valvular changes and
echocardiographic parameters have only been described
in a few studies [19-21] but the influence of gender on
those parameters was not investigated. To our knowl-
edge, this study is the first to report a pronounced aortic
regurgitation in aged male mice compared to age-
matched females, independent of cholesterol levels. This
finding does not appear to be due to estradiol protection
as this result was also confirmed in ovariectomized
females (data not shown). Moreover, we must consider
that the observed sex differences may not simply be
reflective of differences in levels of circulating hormones
[22].
Aortic regurgitation results from malcoaptation of the
aortic leaflets due to abnormalities [8]. In our study, the
observed aortic regurgitation was associated with an
increase in valvular thickness. This has also been
observed in other experimental rodent models [17,19,23]
and humans [24]. Although aortic regurgitation is a
chronic disease characterized by cardiac volume over-
load that induces progressive cardiac hypertrophy and
eventually contractile dysfunction [25,26], neither com-
pensatory cardiac hypertrophy nor pulmonary water
content were observed. This finding is in agreement
with studies done in humans showing that aortic regur-
gitation often remains asymptomatic for decades before
the development of heart failure [17,27]. It has also been
shown that valvular regurgitation could be influenced by
the type of anesthetic used, due to an effect on left ven-
tricular ejection [28,29]. In this study we used a
Figure 3 Typical photomicrographs of aortic valves on a longitudinal axis from a male aged hypercholesterolemic ApoE KO and a
normocholesterolemic C57 mouse. Samples were stained with hematoxylin-eosin (HE), Masson’s trichrome (MT), and von Kossa (VK). Black
arrows indicate diffuse acellularity and myxoid thickening of the spongy layer (HE, MT and VK) in the ApoE KO mouse. Red arrows indicated
valvular fibrosis with dense collagen (MT) mainly in the ApoE KO mouse. Magnification: 250×.
Pereira et al. Lipids in Health and Disease 2010, 9:87
http://www.lipidworld.com/content/9/1/87
Page 5 of 9ketamine and xylazine mixture, the most commonly
used anesthetic during image analysis in mice [28,30].
Although it has been described that this anesthetic
could influence aortic regurgitation by reducing heart
rate [19,23], in our study, males and females had similar
chronotropic activity after the catheterization procedure.
Valvulopathy usually occurs mainly in left-sided
valves, particularly the aortic valve, which could be
sequentially due to mechanical stress, cusp thickening,
inflammation and decrease of cusp pliability, leading to
regurgitation [31]. In agreement with the above study,
we also observed cusp thickening, collagen deposition,
acellularity and aortic regurgitation in aged male mice
of both groups. In addition, the influence of both gender
and hypercholesterolemia on valvular lesions has been
reported only in epidemiological studies [6,32]. Our data
show, for the first time, that male gender and hypercho-
lesterolemia additively contribute to valvular degenera-
tion without aggravation of aortic regurgitation.
In our study, the angiography also revealed the main-
tenance of aorta internal diameter in both C57 and
ApoE KO groups. Ex vivo analysis confirmed this find-
ing and showed an aorta outward remodeling. The vas-
cular remodeling of large arteries is considered an
adaptive structural change observed in both clinical
Figure 4 Typical angiography analysis of the internal diameter (parallel red lines) of the aorta divided into four segments: A)
ascendant aorta - left common carotid; B) left common carotid - descendant thoracic portion of aorta; C) descendant thoracic portion of aorta -
right renal artery; D) descendant thoracic portion of aorta - bifurcation of the common iliac artery. For a better visualization, A and B images
were performed at an angle of 45° whereas C and D were at 0°.
Figure 5 Top panel: typical photomicrographs of cross sections
of ascending aorta showing an augmented vessel diameter in
the hypercholesterolemic ApoE KO compared with the
normocholesterolemic C57 mouse. The sections were stained
with both oil-red-O and hematoxylin (magnification: 400×). Bottom
panel: Bar graphs showing average vessel (white bars) and lumen
(black bars) cross-sectional areas of C57 (n = 6) and ApoE KO (n =
6) mice. Values are mean ± SEM. Numbers in parentheses indicate a
positive remodeling ratio (>1.05). *p < 0.05 compared with vessel
area of C57 groups.
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to a variety conditions, such as atherosclerosis, hyper-
tension and lumen obstruction. Aortic remodeling in
ApoE KO mice is not established in young animals
[7,37] but is detected by 13 months of age [38]. In our
study, we observed that 18-month-old ApoE KO mice
still preserve the aortic vessel lumen compared with
normal animals (C57). Because overcompensation is a
feature of the remodeling response in human coronary
arteries [39], we suggest, as have others [33,40], that the
elderly ApoE KO mouse constitutes a good model for
studies on advanced stages of remodeling mechanism of
large arteries.
Even though aortic remodeling was found to be simi-
lar for both genders in ApoE KO mice, vascular senes-
cence and lipid deposition were influenced by male
gender. Senescent cells show progressive telomere short-
ening [41], negative gene expression regulators [42],
decreased expression of vasodilators [43,44] and
increased proinflammatory molecules [16], contributing
to both progression of atherosclerosis and pathogenesis
of vascular aging [45,46]. In this study, we evaluated
senescence through b-gal activity, which is considered
to be one of the best markers currently available. In
agreement with other studies [41,42], we observed that
hypercholesterolemia promotes inflammation and vascu-
lar senescence. The novelty in this study is the finding
that male gender and hypercholesterolemia have additive
effects on vascular senescence and vessel lipid deposi-
tion. Although estrogens seem to slow the senescence
through activation of estrogen receptors [22,47], ovar-
iectomy did not cause vascular senescence in C57
female mice and did not aggravate it in ApoE KO
females (data not shown). In addition, ovariectomy did
not modify plasma cholesterol levels. Based on other
findings [48], we hypothesized that endogenous and/or
genetic factors could be essential for the development of
vascular senescence.
En face aorta images demonstrated that the localiza-
tion of lipid deposition and vascular senescence in aged
Figure 6 Morphological analysis of aortas in both genders of normocholesterolemic C57 and hypercholesterolemic ApoE KO mice. (A)
typical micrographs showing the severity of calcium deposition (Von Kossa staining; magnification: 250×) and en face images of (B) lipid
deposition (Oil-Red-O staining) and (C) vascular senescence (X-gal, pH 6.0), in ApoE KO mice mainly in the male but not in either male or female
C57 mice.
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turbulent flow area. This finding corroborates the
hypothesis from others [42,46,49] that sites of high
endothelial cell turnover associated with atherogenic sti-
muli can promote telomere shortening and possibly
induction of senescence. We also could expect that oxi-
dative stress and DNA damage contribute to vascular
senescence (or vice-versa) and thus further promote
atherogenesis.
In conclusion, both normocholesterolemic (C57) and
hypercholesterolemic (ApoE KO) elderly mice exhibit
aortic regurgitation, but it is of higher proportion in
males than in females. The notable proportion of
females with absence of aortic regurgitation leaves open
the possibility of a gender-specific protection mechan-
ism. On the other hand, vascular outward (positive)
remodeling observed in hypercholesterolemic mice does
not differ between the genders. Interesting that only vas-
cular lipid deposition and senescence in elderly mice are
influenced by both hypercholesterolemia and male gen-
der, highlighting sex differences in the progression of
vascular diseases in this important model of sponta-
neous atherosclerosis. Although further studies are
needed to reveal the mechanisms underlying these find-
ings, the present data provide significant progress in the
understanding of gender-specific aspects influencing the
development of cardiovascular diseases in order to
improve prevention, diagnosis and develop appropriate
interventions in elderly women and men.
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